ImmunoPrecise, Mila partner on antibody therapeutics

By The Science Advisory Board staff writers

ImmunoPrecise Antibodies and artificial intelligence (AI) research institute Mila have formed a partnership to collaborate on research and talent development initiatives for antibody-based therapeutics.

Specifically, the partnership will apply AI to unexplored datasets generated by ImmunoPrecise's therapeutic antibody discovery platforms to help the design of new therapeutics against life-threatening diseases, according to the companies.

Copyright © 2020

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?